Lee, J., Lee, J. Y., Song, D. W., Bae, H. S., Doo, H. M., Yu, H. S., . . . Choi, B. (2020). Targeted PMP22 TATA-box editing by CRISPR/Cas9 reduces demyelinating neuropathy of Charcot-Marie-Tooth disease type 1A in mice. Nucleic Acids Res.
Citação norma ChicagoLee, Ji-Su, et al. "Targeted PMP22 TATA-box Editing By CRISPR/Cas9 Reduces Demyelinating Neuropathy of Charcot-Marie-Tooth Disease Type 1A in Mice." Nucleic Acids Res 2020.
MLA CitationLee, Ji-Su, et al. "Targeted PMP22 TATA-box Editing By CRISPR/Cas9 Reduces Demyelinating Neuropathy of Charcot-Marie-Tooth Disease Type 1A in Mice." Nucleic Acids Res 2020.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.